Recall Register

Food, drugs, devices › Remel, Inc

Device recall: Campy CVA Medium 100/PK, R01272

FDA enforcement event 98403 · Class II · initiated 5 Feb 2026 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordLenexa, KS

FDA enforcement event 98403 is a device recall by Remel, Inc of Lenexa, KS, initiated 5 Feb 2026 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 572 device enforcement events initiated in 2026 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Remel, Inc has 50 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Remel, Inc, Lenexa, KS.

Reason for recall

"Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium."

Distribution

"US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1474-2026Campy CVA Medium 100/PK, R0127297Class IIOngoing4 Mar 2026

Context

87%of 2026 device events are Class II572 events that year
1product record in this eventfirm median: 1
50events on this register for the firm

Other enforcement events for Remel, Inc

InitiatedProduct (first record)TypeClassRecords
3 Jun 2026GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460DeviceClass II1
24 Mar 2026Yeastone Broth, 11ML, 10/BOX YY3462DeviceClass II1
12 Nov 20251. CAMHB W/LHB, MANUAL, 11ML, 10/BOX YCP112-10 2. BRUCELLA BROTH, 11ML, 10/BOX YT3450DeviceClass II1
11 Jul 2025Blood Agar,5% Sheep Blood 100/PK, Product Number R01202DeviceClass II4
1 May 2025Thermo SCIENTIFIC Sensititre Cation Adjusted AutoRead Mueller-Hinton Broth w/ TES w/ Lysed Horse Blood, REF CP11410; invDeviceClass II1
13 Feb 2025remel BLOOD AGAR MacCONKEY AGAR BIPLATE, REF R02049, QTY 100, for invitro diagnostic useDeviceClass II2
12 Feb 2025Zebra Thermal Barcode Printer GX430t, Model no. YSW 1000 or YSW 2000, may have been sold as an optional accessory for SeDeviceClass II1
20 Sep 2024remel BactiDrop Acridine Orange, REF 21502, 50 per package.DeviceClass II1
14 Aug 2023remel TODD HEWITT W. CNA (LIM BROTH), REF R064810; used to isolate Group B Streptococci form clinical specimens containiDeviceClass II1
31 May 2023Remel Haemophilus Test Medium (Agar) (150mm), 10/pk, REF R04033; and Remel Haemophilus Test Medium (Agar)(100mm), 10/pk,DeviceClass II1

All 50 events for Remel, Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.